InnoCan Pharma
(OTC) INNPF
InnoCan Pharma Financials at a Glance
Market Cap
$11.02M
Revenue (TTM)
$25.19M
Net Income (TTM)
-$1.50M
EPS (TTM)
-$0.34
P/E Ratio
-7.28
Dividend
$0.00
Beta (Volatility)
1.84 (High)
Dividend
$0.00
Beta (Volatility)
1.84 (High)
Price
$2.45
Volume
200
Open
$2.35
Price
$2.45
Volume
200
Open
$2.35
Previous Close
$2.45
Daily Range
$2.35 - $2.45
52-Week Range
$0.13 - $14.26
Estimated Earnings Date
Nov 19, 2025
Dividend
$0.00
Beta (Volatility)
1.84 (High)
Price
$2.45
Volume
200
Open
$2.35
Previous Close
$2.45
Daily Range
$2.35 - $2.45
52-Week Range
$0.13 - $14.26
Estimated Earnings Date
Nov 19, 2025
INNPF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout InnoCan Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
9
CEO
Iris Or Gabi Bincovich
Website
www.innocanpharma.comHeadquarters
Calgary, AB T2P 0N7, CA
INNPF Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-10%
Net Income Margin
-6%
Return on Equity
-31%
Return on Capital
-28%
Return on Assets
-14%
Earnings Yield
-13.74%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.02M
Shares Outstanding
4.50M
Volume
200
Avg. Volume
52.984
Financials (TTM)
Gross Profit
$23.93M
Operating Income
-$1.26M
EBITDA
$130.00K
Operating Cash Flow
$495.00K
Capital Expenditure
-$16.00K
Free Cash Flow
$479.00K
Cash & ST Invst.
$6.69M
Total Debt
$930.00K
InnoCan Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.38M
-18.2%
Gross Profit
$5.81M
-18.4%
Gross Margin
91.11%
N/A
Market Cap
$11.02M
N/A
Market Cap/Employee
$1.00M
N/A
Employees
11
N/A
Net Income
-$958.54K
-64.7%
EBITDA
-$767.22K
-1767.9%
Quarterly Fundamentals
Net Cash
$5.27M
+4.2%
Accounts Receivable
$1.31M
+20.4%
Inventory
$2.19M
-26.0%
Long Term Debt
$969.18K
-25.6%
Short Term Debt
$453.49K
+6378.4%
Return on Assets
-13.80%
N/A
Return on Invested Capital
-28.28%
N/A
Free Cash Flow
-$498.99K
-237.5%
Operating Cash Flow
-$498.99K
-235.6%